PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

USC researchers discover genetic mutation causing excessive hair growth

2011-06-04
(Press-News.org) Los Angeles, Calif., June 2, 2011—Researchers in the Keck School of Medicine of the University of Southern California (USC), together with scientists in Beijing, China, have discovered a chromosomal mutation responsible for a very rare condition in which people grow excess hair all over their bodies. Investigators hope the finding ultimately will lead to new treatments for this and less severe forms of excessive hair growth as well as baldness.

The study, "X-linked congenital hypertrichosis syndrome is associated with interchromosomal insertions mediated by a human-specific palindrome near SOX3," will appear in the June 2, 2011 issue of the American Journal of Human Genetics.

Pragna Patel, professor in the Keck School, the USC Institute for Genetic Medicine, and the Herman Ostrow School of Dentistry of USC, is a co-investigator of the study, and Sunju Choi, a research associate in Patel's lab, is a co-first author. The principal investigator is Xue Zhang, professor and chair of medical genetics at the Peking Union Medical College.

The initial discovery of the mutation came from Zhang's lab, which examined the condition, known as CGH, in a Chinese family. Researchers there worked with Choi to confirm the finding in a Mexican family that Patel first began studying in 1993. Males with this disorder have hair covering their entire face including their eyelids and their upper body, while females have thick patches of hair on their bodies.

"In 1995, we traced the approximate location of the mutation responsible for CGH to a section of the X chromosome in the Mexican family," said Patel, whose laboratory focuses on understanding the genetic basis of inherited diseases. "We sequenced nearly 100 genes but could not find any mutations. Then recently, Xue Zhang and his colleagues in Beijing were able to pinpoint the exact location, discovering that there was an insertion of chromosome 5 into the X chromosome in the Chinese family. When the Mexican family was examined, a piece of chromosome 4 was found to be inserted into the same part of the X chromosome, thus confirming that these extremely rare events caused the disorder."

The investigators suggest that insertion of the "extra" DNA sequences into the X chromosome apparently turns on a gene, likely SOX3, located near the insertion site. SOX3 is a strong candidate because other members of this gene family have been shown to play a role in hair growth.

In addition, the insertion has occurred within a block of DNA sequence called a "palindrome," in which the sequence of the four building blocks of DNA (akin to letters of the alphabet) read exactly the same as their complementary sequences, but in the reverse direction. The particular palindrome at the site that the researchers studied is only found in humans.

"We don't yet know the significance of the palindromic sequence in this case," Patel said. "But it appears to be unstable, and can be entirely absent in many individuals with normal hair growth. It's only when there is insertion of certain chromosome segments at this site that people have extra hair."

Earlier, researchers had theorized that the CGH mutation is "atavistic" – a trait that reappears after being absent for a long time. One example of an atavistic trait is extra nipples in both men and women.

"It's like the information is there in the genome, but is silenced," Patel said. "Then somehow it's reactivated, and can manifest as the trait. We don't know yet if this is the case with CGH."

Further studies will test if this is indeed true. "If in fact the inserted sequences turn on a gene that can trigger hair growth, it may hold promise for treating baldness or hirsutism [excessive hair growth] in the future, especially if we could engineer ways to achieve this with drugs or other means," Patel said.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment

Matching targeted therapies to tumors specific gene mutations key to personalized cancer treatment
2011-06-04
CHICAGO — Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center. MD Anderson's Phase I findings were presented today on the opening press program of the 47th Annual Meeting of the American Society of Clinical Oncology. Apostolia-Maria Tsimberidou, M.D., Ph.D., associate professor in MD Anderson's Department of Investigational Cancer Therapeutics, and the study's principal ...

Benefit of targeted lung cancer therapy confirmed

2011-06-04
AURORA, Colo. (June 3, 2011) – A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO). The patients taking crizotinib have anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) and the drug targets the gene ...

Vaccine first to show improved survival rates for metastatic melanoma

2011-06-04
(CHICAGO) – For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival. The findings of the study were published in the June 2 issue of New England Journal of Medicine. This marks the first vaccine study in the disease and one of the first in all cancers to show clinical benefit in a randomized Phase III clinical trial. "This is the first time that a vaccine has shown benefit ...

Cancer survivors can't shake pain, fatigue, insomnia, foggy brain

2011-06-04
CHICAGO --- When people finish treatment for cancer, they want to bounce back to their former vital selves as quickly as possible. But a new Northwestern Medicine study -- one of the largest survivor studies ever conducted – shows many survivors still suffer moderate to severe problems with pain, fatigue, sleep, memory and concentration three to five years after treatment has ended. "We were surprised to see how prevalent these symptoms still are," said study co-investigator Lynne Wagner, an associate professor of medical social sciences at Northwestern University Feinberg ...

River mystery solved

River mystery solved
2011-06-04
The pristine state of unpolluted waterways may be their downfall, according to research results published in a paper this week in the journal Geophysical Research Letters. A species of freshwater algae that lives in streams and rivers, called Didymo for Didymosphenia geminata, is able to colonize and dominate the bottoms of some of the world's cleanest waterways--precisely because they are so clear. Didymo does so with a little help from its friends--in this case, bacteria--which allow it to make use of nutrients like phosphorus. Blooms of Didymo, also known as "rock ...

Maple Online Casino Makes Big Winners

2011-06-04
Malta - May 2011 - Celebrations are certainly underway in D. R.'s household today, because he has just won over $82,000 playing at Maple Online Casino. He won a few prizes while playing different games, which makes his winnings even more impressive. D. R. won $61,522.00 while playing Hitman; $12,050.00 on Multi-Hand European Blackjack; and $9,350.00 while playing Classic Blackjack. Thus, all his winnings for the day equal $82,922.00. Casino Manager, Charlotte Jackson, was available for comment. "Congratulations D. R. We are very proud of your accomplishments ...

Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drug

2011-06-04
CHICAGO -- ASCO Abstract #10504. Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin, according to a study by Mayo Clinic and North Central Cancer Research Group (NCCTG) investigators. The study, which looked at tumors from 1,802 patients enrolled in the NCCTG N9831 clinical trial, found that patients with HER2-positive breast cancer and had either a loss of PTEN functioning or normal PTEN activity did equally well when Herceptin was added to chemotherapy to prevent ...

Combination antibody therapy shows promise in metastatic melanoma

2011-06-04
BOSTON--A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators. The findings (abstract 8511), will be presented in an oral session at the annual meeting of the American Society of Clinical Oncology on Saturday, June 4, 3 p.m. CT, Arie Crown Theater, McCormick Place. The drugs -- ipilimumab and bevacizumab -- are both monoclonal antibodies, intensified ...

NASA watching 2 areas in the Caribbean, 1 is a rainmaker

NASA watching 2 areas in the Caribbean, 1 is a rainmaker
2011-06-04
There are two low pressure areas in the Caribbean Sea for future development into tropical cyclones, although the chances are near zero for one, and minimal for the other. The GOES-13 satellite has been following the life of System 93L, which is one of those systems. The second low pressure area may not develop over the weekend, but threatens heavy rain in Hispaniola, Cuba and Jamaica. The GOES-13 satellite provides images of the U.S. east coast, Atlantic and Caribbean Sea continually every day. In an image from 1731 UTC (1:31 p.m. EDT) today, June 3, the low pressure ...

Silberstein, Awad & Miklos Joins Environmental Alliance

2011-06-04
Silberstein, Awad & Miklos, P.C., is doing more to help New Yorkers by making a commitment to improve its environmental profile. The firm has long been the voice of those hurt by medical errors, but now it hopes to promote awareness of eco-friendly business practices for lawyers through the B2B Green Alliance. The B2B Green Alliance is sponsored by web marketing firm Page 1 Solutions, part of Page 1 Green Solutions, an environmental commitment program. Page 1 Solutions strives to become a positive force for change not only by following eco-conscious practices in ...

LAST 30 PRESS RELEASES:

New findings could lead to better treatment for blood cancer

Expanded research on COPD and metabolic syndrome would advance patient-centered care

Mount Sinai-led team enhances automated method to detect common sleep disorder affecting millions

Dr. Ruth Westheimer, Dr. Helen Fisher, and Dr. Judith Allen donate historic archives to the Kinsey Institute

Bridging oceans: A US-Japan approach to flood risk and climate resilience

Dense human population is linked to longer urban coyote survival

Science educator calls for climate change to be taught more in US schools

Realistic emission tests for motorbikes, mopeds and quads

Race- and gender-based microaggressions linked to higher post-birth blood pressure

Novel ‘quantum refrigerator’ is great at erasing quantum computer’s chalkboard

States struggle to curb food waste despite policies

Record cold quantum refrigerator paves way for reliable quantum computers

New discovery makes organic solar cells more efficient and stable

What we eat affects our health — and can alter how our genes function

Lung cancer test predicts survival in early stages better than current methods

Pioneering new mathematical model could help protect privacy and ensure safer use of AI  

Floods, droughts, then fires: Hydroclimate whiplash is speeding up globally

Scientists fuel sustainable future with catalyst for hydrogen from ammonia

Discovering hidden wrinkles in spacecraft membrane with a single camera

Women are less likely to get a lung transplant than men and they spend six weeks longer on the waiting list

Study sheds more light on life expectancy after a dementia diagnosis

Tesco urged to drop an “unethical” in-store infant feeding advice service pilot

Unraveling the events leading to multiple sex chromosomes using an echidna genome sequence

New AI platform identifies which patients are likely to benefit most from a clinical trial

Unique Stanford Medicine-designed AI predicts cancer prognoses, responses to treatment

A new ultrathin conductor for nanoelectronics

Synthetic chemicals and chemical products require a new regulatory and legal approach to safeguard children’s health

The genes that grow a healthy brain could fuel adult glioblastoma

New MSU study explains the delayed rise of plants, animals on land

UTA becomes one of largest natural history libraries

[Press-News.org] USC researchers discover genetic mutation causing excessive hair growth